Rifamycin SV

Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.

Cross Reference

Introduction

To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Rifamycin SV?

Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Rifamycin SV

MeSH term MeSH ID Detail
Diarrhea D003967 32 associated lipids
Pain D010146 64 associated lipids
Abscess D000038 13 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Osteomyelitis D010019 10 associated lipids
Alzheimer Disease D000544 76 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Anaphylaxis D000707 35 associated lipids
Per page 10 20 | Total 18

PubChem Associated disorders and diseases

What pathways are associated with Rifamycin SV

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Rifamycin SV?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Rifamycin SV?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

What genes are associated with Rifamycin SV?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Rifamycin SV

Download all related citations
Per page 10 20 50 100 | Total 175
Authors Title Published Journal PubMed Link
Caruso I et al. Prevention of appearance of radiological lesions in early rheumatoid arthritis: a randomized, single-blind study comparing intra-articular rifamycin with auranofin. 1992 J. Int. Med. Res. pmid:1568521
Kukiełka E and Cederbaum AI Stimulation of microsomal production of reactive oxygen intermediates by rifamycin SV: effect of ferric complexes and comparisons between NADPH and NADH. 1992 Arch. Biochem. Biophys. pmid:1329662
Eichler HG et al. Studies on the uptake of low molecular weight monomeric tris-galactosyl conjugates by the rat liver. 1992 Biochem. Pharmacol. pmid:1472076
Mancuso G and Masarà N Contact urticaria and severe anaphylaxis from rifamycin SV. 1992 Contact Derm. pmid:1395622
Caruso I et al. Clinical improvement in ankylosing spondylitis with rifamycin SV infiltrations of peripheral joints. 1992 J. Int. Med. Res. pmid:1521673
Sáez GT et al. Effect of metal ion catalyzed oxidation of rifamycin SV on cell viability and metabolic performance of isolated rat hepatocytes. 1991 Biochim. Biophys. Acta pmid:2049402
Renoult E et al. Effect of topical rifamycin SV treatment on cyclosporin A blood levels in a renal transplant recipient. 1991 Eur. J. Clin. Pharmacol. pmid:2050183
Quinlan GJ and Gutteridge JM DNA base damage by beta-lactam, tetracycline, bacitracin and rifamycin antibacterial antibiotics. 1991 Biochem. Pharmacol. pmid:1930286
Chernov AP et al. Recombinant reverse transcriptase of Rous sarcoma virus: characterization of DNA polymerase and RNAase H activities. 1991 Biomed. Sci. pmid:1717011
Setti G et al. The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SV. 1990 Oct-Dec Chir Organi Mov pmid:2098221
Dylan T et al. Hypoosmotic adaptation in Rhizobium meliloti requires beta-(1----2)-glucan. 1990 J. Bacteriol. pmid:1689716
Traxler P et al. Hypolipidemic activity of rifamycin derivatives. 1990 J. Med. Chem. pmid:2299623
Iselin F et al. [Comparative study of the effects of a local antibiotic and a local antiseptic in emergency hand surgery]. 1990 Ann Chir Main Memb Super pmid:2346354
Cavalleri B et al. Synthesis and biological activity of some derivatives of rifamycin P. 1990 J. Med. Chem. pmid:2329569
Kenny MT et al. Comparative effect of the naphthalenic ansamycins rifamycin SV, rifampin and cyclopentylrifampicin on murine neutrophil function. 1989 Int. J. Immunopharmacol. pmid:2559042
Vékey K et al. Liquid chromatographic-mass spectrometric studies on rifamycin antibiotics. 1989 J. Chromatogr. pmid:2768398
Wondrak EM et al. Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs. 1988 J. Antimicrob. Chemother. pmid:2452149
Passamonti S and Sottocasa GL The quinoid structure is the molecular requirement for recognition of phthaleins by the organic anion carrier at the sinusoidal plasma membrane level in the liver. 1988 Biochim. Biophys. Acta pmid:3401473
Caruso I Rifamycin SV in the local treatment of synovitis. 1987 J. Rheumatol. pmid:3572924
Quinlan GJ and Gutteridge JM Oxygen radical damage to DNA by rifamycin SV and copper ions. 1987 Biochem. Pharmacol. pmid:2823829
Furet Y et al. [Mixed hepatitis due to rifamycin SV. Apropos of a case]. 1986 Sep-Oct Therapie pmid:3810533
Michelson AM Pro-oxidant action of superoxide dismutase in the autoxidation of rifamycin SV. 1986 Free Radic. Res. Commun. pmid:2577735
Gao DZ [Determination of rifampin, rifamdin and rifocin concentrations in the CSF of 71 patients with tuberculous meningitis]. 1986 Zhonghua Yi Xue Za Zhi pmid:3094900
Hanzlik J et al. [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"]. 1986 Ann Univ Mariae Curie Sklodowska Med pmid:3154057
Yu WH et al. [Study of incompatibility in vitro of injection of rifamycin sodium with 45 injections]. 1986 Hua Xi Yi Ke Da Xue Xue Bao pmid:3804311
Babasaki K et al. Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis. 1985 J. Biochem. pmid:3936839
Gentile S et al. The implication of bilitranslocase function in the impaired rifamycin SV metabolism in Gilbert's syndrome. 1985 Clin. Sci. pmid:2485269
Gentile S et al. Impaired plasma clearance of nicotinic acid and rifamycin-SV in Gilbert's syndrome: evidence of a functional heterogeneity. 1985 Hepatogastroenterology pmid:4018705
Lindblad S et al. Rifamycin SV in local treatment of synovitis--a clinical, arthroscopic and pharmacologic evaluation. 1985 J. Rheumatol. pmid:4087269
Gentile S et al. Plasma clearance of nicotinic acid and rifamycin-SV, and their interaction in Gilbert's syndrome: application of a compartmental model. 1984 Hepatogastroenterology pmid:6724499
Bruni L et al. Herpes zoster treatments: results of a clinical trial relative to the use of rifamycin SV versus neuramide. 1984 J. Int. Med. Res. pmid:6381169
Deshko TN et al. [Physico-chemical properties of DNA-dependent RNA-polymerase from Escherichia coli and its subunits]. 1984 Bioorg. Khim. pmid:6388581
Brufani M et al. The synthesis of 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives. 1984 J. Antibiot. pmid:6526730
Freymuth F et al. [In vitro activity of rifamycin SV on herpes simplex and herpes varicella viruses]. 1983 May-Jun Therapie pmid:6310814
Revuz J et al. [Generalization of zona in a nonimmunosuppressed patient receiving isoprinosine and rifamycin SV]. 1983 Ann Dermatol Venereol pmid:6195953
Arora SK Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV. 1983 Mol. Pharmacol. pmid:6865897
Dekio S and Jidoi J Mechanism of coagulase production in Staphylococcus aureus Smith. 1983 Zentralbl Bakteriol Mikrobiol Hyg A pmid:6673416
Vogt E [Effects of rifamycin SV and a neomycin-bacitracin combination on the healing of microbial eczema]. 1983 Z. Hautkr. pmid:6649743
Craven N and Anderson JC Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice. 1983 Am. J. Vet. Res. pmid:6553464
Fernandes D and Giacinti F [Agranulocytosis induced by rifamycin SV in a patient with Hodgkin's disease. Immunologic considerations and pathogenetic interpretations]. 1982 Jan-Jun G Batteriol Virol Immunol pmid:7187341
Păunescu E et al. [Preliminary results of the use of a new derivative of rifamycin SV in the treatment of sarcoidosis]. 1982 Apr-Jun Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol pmid:6294806
Ghisalba O et al. Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis. 1982 J. Antibiot. pmid:7200089
Amagai T et al. The effect of ribavirin and rifamycin SV on age-dependent changes of the immune system during the adult life of SJL mice. 1982 Immunol. Lett. pmid:6210629
Kono Y Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide. 1982 J. Biochem. pmid:6279585
Kono Y and Sugiura Y Electron spin resonance studies on the oxidation of rifamycin SV catalyzed by metal ions. 1982 J. Biochem. pmid:6279586
Nikiforov VG et al. A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli. 1982 FEBS Lett. pmid:6761147
Quinn FR The quantitative structure-activity relationship of rifamycin B amide and hydrazide toxicity in mice. 1982 Farmaco Sci pmid:7056391
Cottafava F et al. [Rheumatoid synovitis of the knee, treated successfully with intra-articular rifamycin SV]. 1982 Minerva Pediatr. pmid:7070359
Spisani S et al. The effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis. 1982 Scand. J. Rheumatol. pmid:7089503
Caruso I et al. Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. 1982 Ann. Rheum. Dis. pmid:7046652